Time-Restricted G-Protein Signaling Pathways via GPR176, G


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Jul 2020
Historique:
received: 27 06 2020
revised: 15 07 2020
accepted: 16 07 2020
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

G-protein-coupled receptors (GPCRs) are an important source of drug targets with diverse therapeutic applications. However, there are still more than one hundred orphan GPCRs, whose ligands and functions remain unidentified. The suprachiasmatic nucleus (SCN) is the central circadian clock of the brain, directing daily rhythms in activity-rest behavior and physiology. Malfunction of the circadian clock has been linked to a wide variety of diseases, including sleep-wake disorders, obesity, diabetes, cancer, and hypertension, making the circadian clock an intriguing target for drug development. The orphan receptor GPR176 is an SCN-enriched orphan GPCR that sets the pace of the circadian clock. GPR176 undergoes asparagine (

Identifiants

pubmed: 32709014
pii: ijms21145055
doi: 10.3390/ijms21145055
pmc: PMC7404074
pii:
doi:

Substances chimiques

RGS Proteins 0
RGS16 protein 0
Receptors, G-Protein-Coupled 0
Cyclic AMP E0399OZS9N

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : The Ministry of Education, Culture, Sports, Science and Technology of Japan
ID : 17H01524
Organisme : The Ministry of Education, Culture, Sports, Science and Technology of Japan
ID : 15H05933
Organisme : The Project for Elucidating and Controlling Mechanisms of Ageing and Longevity of the Japan Agency for Medical Research and Development
ID : JP19gm5010002
Organisme : The Basis for Supporting Innovative Drug Discovery and Life Science Research program of the Japan Agency for Medical Research and Development
ID : JP19am0101092

Références

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3657-62
pubmed: 26966234
Pharmacol Ther. 2007 Dec;116(3):473-95
pubmed: 18006065
FEBS Lett. 1995 Sep 18;372(1):99-102
pubmed: 7556653
Science. 2008 May 16;320(5878):949-53
pubmed: 18487196
Nat Commun. 2019 Jun 12;10(1):2563
pubmed: 31189882
Nat Commun. 2011;2:327
pubmed: 21610730
Nat Commun. 2016 Mar 09;7:10889
pubmed: 26955885
PLoS One. 2017 Oct 31;12(10):e0187411
pubmed: 29088301
PLoS Genet. 2016 Aug 05;12(8):e1006125
pubmed: 27494321
J Biol Chem. 1989 Jan 5;264(1):409-18
pubmed: 2491850
Science. 2000 Apr 28;288(5466):682-5
pubmed: 10784453
Nat Med. 2010 Jan;16(1):67-74
pubmed: 20023637
Cell Host Microbe. 2019 Aug 14;26(2):273-282.e7
pubmed: 31378678
Biochem J. 2001 Jul 1;357(Pt 1):73-81
pubmed: 11415438
FEBS Open Bio. 2017 Nov 20;7(12):1982-1993
pubmed: 29226084
Cell. 2019 May 30;177(6):1436-1447.e12
pubmed: 31150620
J Biol Chem. 1990 Feb 5;265(4):2383-90
pubmed: 2105321
Nat Rev Neurosci. 2018 Aug;19(8):453-469
pubmed: 29934559
Science. 2018 Mar 16;359(6381):
pubmed: 29439024
Curr Biol. 2003 Apr 15;13(8):664-8
pubmed: 12699623
Nature. 2011 Jan 27;469(7331):498-503
pubmed: 21270888
Nat Neurosci. 2005 Apr;8(4):476-83
pubmed: 15750589
Nature. 2012 May 16;485(7399):459-64
pubmed: 22622569
Neuron. 2015 Mar 4;85(5):1103-16
pubmed: 25741730
Sci Rep. 2020 Mar 10;10(1):4429
pubmed: 32157140
Cell. 2019 May 30;177(6):1448-1462.e14
pubmed: 31150621
Cell Signal. 2002 Mar;14(3):249-57
pubmed: 11812653
Endocr J. 2017 Jun 29;64(6):571-579
pubmed: 28502923
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10691-6
pubmed: 17563389
J Biol Chem. 1990 May 15;265(14):8243-51
pubmed: 2159473
J Comp Neurol. 2012 Aug 15;520(12):2730-41
pubmed: 22684939
Cell. 2019 Oct 31;179(4):895-908.e21
pubmed: 31675498
J Neurochem. 2018 Dec;147(6):730-747
pubmed: 30092607
Nat Commun. 2016 Feb 17;7:10583
pubmed: 26882873
Oncogene. 2001 Mar 26;20(13):1615-25
pubmed: 11313909
Neuron. 2015 Mar 4;85(5):1086-102
pubmed: 25741729
Nat Rev Drug Discov. 2017 Jan;16(1):19-34
pubmed: 27910877
Genes Dev. 2018 Mar 1;32(5-6):347-358
pubmed: 29572261
Trends Endocrinol Metab. 2019 Sep;30(9):569-571
pubmed: 31375394
PLoS One. 2011 Mar 09;6(3):e17655
pubmed: 21408016
Nature. 2017 Sep 7;549(7670):48-53
pubmed: 28854168
Nat Struct Mol Biol. 2015 May;22(5):362-9
pubmed: 25895059
Cell Metab. 2019 Aug 6;30(2):238-250
pubmed: 31390550
J Biol Chem. 1997 Jan 24;272(4):2223-9
pubmed: 8999927
FEBS Lett. 1993 Nov 8;334(1):3-8
pubmed: 8224221
Science. 1990 Feb 23;247(4945):975-8
pubmed: 2305266
Int J Mol Sci. 2019 Apr 23;20(8):
pubmed: 31018551
Nat Commun. 2016 Feb 02;7:10448
pubmed: 26835600
PLoS One. 2015 Sep 18;10(9):e0138463
pubmed: 26384023
Nat Commun. 2019 Jan 29;10(1):343
pubmed: 30696823
Science. 2013 Oct 4;342(6154):85-90
pubmed: 24092737
Nat Rev Genet. 2017 Mar;18(3):164-179
pubmed: 27990019
J Biol Chem. 2015 Jul 24;290(30):18379-90
pubmed: 26045554
J Neurosci. 2000 May 1;20(9):3095-103
pubmed: 10777773
Genes Dev. 2018 Jan 15;32(2):140-155
pubmed: 29440246
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14306-11
pubmed: 21788520
Biol Pharm Bull. 2012;35(9):1385-91
pubmed: 22975484
J Neurosci. 1987 Jun;7(6):1626-38
pubmed: 3598638
Cold Spring Harb Perspect Biol. 2017 Jan 3;9(1):
pubmed: 28049647
Cell. 2017 Jul 27;170(3):414-427
pubmed: 28753422

Auteurs

Shumpei Nakagawa (S)

Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyō-ku, Kyoto 606-8501, Japan.

Khanh Tien Nguyen Pham (KT)

Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyō-ku, Kyoto 606-8501, Japan.

Xinyan Shao (X)

Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyō-ku, Kyoto 606-8501, Japan.

Masao Doi (M)

Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyō-ku, Kyoto 606-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH